AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtoss 2mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Astonea Labs Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimtoss 2mg/500mg Tablet PR

Diabex Duo 2mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication assists in regulating blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical advice can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt treatment with fast-acting glucose (e.g., sugary foods, juice) is essential; consistent meal timing and carrying glucose sources are advised. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended by your doctor.

Uses of Glimtoss 2mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Glimtoss 2mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Glimtoss 2mg/500mg Tablet PR with a meal.

Common Side effects of Glimtoss 2mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtoss 2mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Glimtoss 2mg/500mg Tablet PR with a meal.

How Glimtoss 2mg/500mg Tablet PR works:

Glimtoss 2mg/500mg tablets (PR) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimtoss 2mg/500mg Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimtoss 2mg/500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against possible risks prior to prescription. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

The use of Glimtoss 2mg/500mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimtoss 2mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimtoss 2mg/500mg Tablet PR is contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimtoss 2mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dose; it's contraindicated in cases of severe liver disease.

What if you forget to take Glimtoss 2mg/500mg Tablet PR :

Should you forget a Glimtoss 2mg/500mg Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimtoss 2mg/500mg Tablet PR

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimtoss 2mg/500mg Tablet PR

Store this medication in its original, tightly sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Glimtoss 2mg/500mg Tablet PR carries a risk of lactic acidosis, a serious, potentially life-threatening condition resulting from excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare but significant adverse reaction is particularly concerning for individuals with impaired kidney function, the elderly, or those consuming substantial alcohol. Characteristic symptoms include muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimtoss 2mg/500mg Tablet PR use and seek immediate medical attention.
Glimepiride/Metformin 2mg/500mg tablets (PR) combine two agents to manage type 2 diabetes mellitus (DM) in adults. This medication enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. This dual therapy is unsuitable for type 1 DM.
Glimtoss 2mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, prolonged Glimtoss 2mg/500mg Tablet PR administration can lead to Vitamin B12 insufficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of annually, has been proposed by some investigators.
Indeed, Glimtoss 2mg/500mg tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, diligent blood glucose monitoring is crucial. Carrying readily available glucose, such as tablets, honey, or fruit juice, is strongly recommended.
Combining Glimtoss 2mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimtoss 2mg/500mg Tablet...
74
MRP 90
17% off